Dr. Krishnan is the Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope in Duarte, CA. She is also Associate Director, Medical Education & Training Program, Department of Hematology & Hematopoietic at City of Hope. She is board certified in Hematology and Medical Oncology and serves as Attending Physician at City of Hope Comprehensive Cancer Center. Dr. Krishnan received her B.S (Cum Laude, Phi Beta Kappa) from Union College in Schenectady, NY and her medical degree from Albany Medical College as part of an accelerated six year medical program where she was inducted into the AOA medical honor society. She completed her residency in Medicine at University of Rochester and fellowship in Hematology/Oncology at New England Deaconess Hospital and Dana Farber Cancer Institute at Harvard Medical School. Her primary research interests include multiple myeloma and has participated in over 50 clinical studies as an individual or principal investigator. Dr. Krishnan’s research has been published in numerous medical journals including Blood, Lancet Oncology and New England Journal of Medicine.
Amrita Krishnan, M.D., F.A.C.P.
Professor, Department of Hematology & Hematopoietic Cell Transplantation at City of Hope, Duarte, CA
John Leonard, M.D.
Associate Dean of Clinical Research, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Division of Hematology-Oncology, Vice Chairman Weill Department of Medicine, Weill Cornell Medicine, New York, NY
Dr. Leonard is the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Associate Dean for Clinical Research at Weill Cornell Medicine and Vice Chairman of the Weill Department of Medicine. He has board certifications in Hematology and Medical Oncology and serves as Attending Physician at Weill Cornell Medicine and New York Presbyterian Hospital. Dr. Leonard received his undergraduate degree from Johns Hopkins University and his medical degree from the University of Virginia School of Medicine. He completed his residency in Medicine at New York Hospital – Cornell Medical Center/Memorial Sloan-Kettering Cancer Center and fellowship in Hematology-Oncology at New York Presbyterian Hospital – Cornell Medical Center. His primary research interests include novel therapeutic strategies for the treatment of lymphoma and related hematologic malignancies, and has participated in over 50 clinical studies as an individual or principal investigator. Dr. Leonard’s research has been published in numerous medical journals, and he has served as a member of the editorial boards of Blood and Journal of Clinical Oncology. He is the Lymphoma Committee Chair of the Alliance for Clinical Trials in Oncology, a National Cancer Institute-supported cooperative group in the National Clinical Trials Network.
R. Wendel Naumann, M.D.
Director of Minimally Invasive Surgery in Gynecologic Oncology and Professor in Department of Ob/Gyn at Carolinas Medical Center – Levine Cancer Institute in Charlotte, North Carolina
Dr. Naumann is currently the Director of Minimally Invasive Surgery in Gynecologic Oncology and Professor in Department of Ob/Gyn at Carolinas Medical Center – Levine Cancer Institute in Charlotte, North Carolina. He did his residency in Obstetrics and Gynecology as well as his fellowship in Gynecologic Oncology at the University of Alabama School of Medicine in Birmingham. He has served as a board member on the Executive Council of the Society of Gynecologic Oncology (SGO) and the Chair of Education Committee and is currently the co-director of the SGO Winter meeting. He has an interest in chemotherapy development including targeted therapies and immune therapies and runs the phase I trials in gynecologic oncology at the Levine Cancer Institute. He and has served as a member of the GOG/NRG corpus committee and the Developmental Therapeutics committee.
Richard T. Penson, MRCP, M.D.
Associate Professor of Medicine at Harvard Medical School, and Clinical Director of Medical Gynecologic Medical Oncology at Massachusetts General Hospital, Boston, MA
Dr. Penson is Associate Professor of Medicine at Harvard Medical School, and Clinical Director of Medical Gynecologic Medical Oncology at Massachusetts General Hospital. Dr. Penson came from St Bartholomew’s Hospital, London, in 1997 and his practice is devoted almost exclusively to Gynecologic Oncology, although he attends on the Bigelow General Medical Service at Mass General and does general oncology on Martha’s Vineyard. Dr. Penson served in multiple leadership positions and sits on the national NRG (Gynecologic Oncology Group) committees for ovarian cancer and quality of life research, and the NCCN Ovarian Committee. Dr. Penson is one of the chairs of the Institutional Review Board of Dana-Farber/Partners CancerCare, and teaches Harvard medical students on the Practice of Medicine course.